CorMedix, Inc. (CRMD)
7.09
+0.03
(+0.42%)
USD |
NASDAQ |
Jan 14, 16:00
7.15
+0.06
(+0.85%)
After-Hours: 05:29
CorMedix SG&A Expense (TTM): 75.56M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Amicus Therapeutics, Inc. | 353.07M |
| Pfizer Inc. | 13.91B |
| Arcutis Biotherapeutics, Inc. | 253.18M |
| ANI Pharmaceuticals, Inc. | 304.67M |
| Alkermes Plc | 661.32M |